Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoire IPRAD is a French pharmaceutical company specializing in women's health and family well-being. Founded in 1989, the company has established itself as a leader in the French gynecology market with flagship brands such as Saforelle, Mucogyne, and Gestarelle. Its product portfolio includes over-the-counter (OTC) medicines, medical devices, food supplements, and dermo-cosmetic products. In 2020, IPRAD was acquired by HRA Pharma, which was subsequently acquired by Perrigo Company plc in 2022. Today, IPRAD continues to operate as a key brand within Perrigo's consumer self-care portfolio, focusing on innovative solutions for intimate hygiene, pregnancy, and general health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoire IPRAD.